FDAnews
www.fdanews.com/articles/73672-jazz-pharmaceuticals-completes-acquisition

JAZZ PHARMACEUTICALS COMPLETES ACQUISITION

June 27, 2005

Jazz Pharmaceuticals has announced that it has completed the previously announced acquisition of Orphan Medical. "The addition of Orphan Medical's products and experienced specialty sales force establishes our commercial presence in our neurology and psychiatry franchises," said Robert Myers, executive vice president and chief business officer of Jazz Pharmaceuticals. "We are excited about continuing the clinical development of Xyrem, and we look forward to growing our commercial activities, both through acquiring additional products and by launching products from our internal product development pipeline."

PharmaLive (http://www.medadnews.com/News/Index.cfm?articleid=251686)